Scientific research is increasingly driven by multiomics approaches that integrate proteomic, metabolomic, and lipidomic data to better understand complex biological systems. As datasets grow larger and more detailed, researchers face mounting challenges around sensitivity, throughput, reproducibility, and data interpretation.

In this Tell Us What You Know episode, Paul Baker from SCIEX shares how researchers can navigate the rapidly evolving omics landscape, address persistent challenges in sensitivity and throughput, and apply advances in mass spectrometry to generate deeper, more reliable insights in translational and pharmaceutical research.

Watch this episode to learn:

• How mass spectrometry fits into today’s rapidly evolving omics landscape
• What improved sensitivity means for detecting low-abundance biomarkers and supporting clinical research
• How accurate mass spectrometry platforms can be applied across proteomics, metabolomics, lipidomics, and translational workflows